Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

Cardiology
Anthony Chau
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study (TAMBE PAS)
Aortic Aneurysm

Study Description

A maximum of 300 adult subjects will be enrolled at up to 60 U.S. centers, with a minimum of 70 subjects enrolled at study centers with no prior experience using the TAMBE Device. Subjects will have follow-up at 1 month, 6 months, 12 months and annually thereafter through 10 years post implant.

Eligibility

The subject is / has:

  1. Treated with the aortic component of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Aortic Component) to allow endovascular repair of an aortic disease involving the visceral vessels.
  2. Age greater than or equal to 18 years at the time of informed consent signature.
  3. An Informed Consent Form signed by subject or legal representative.

The subject is / has:

  1. Any contraindications for the TAMBE Device according to the IFU.
  2. Planned parallel grafting with the TAMBE Aortic Component.
  3. Intent to modify TAMBE Aortic Component (e.g., in situ fenestration).
A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.